Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes

Drug and Alcohol Dependence

Volumn 113, Issue 2-3, 2011, Pages 249-251

  Mariani, John J ^a,b   Brooks, Daniel ^a   Haney, Margaret ^a,b   Levin, Frances R ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

Clinical trial methods; Marijuana; Measurement

Indexed keywords

CANNABIS;

ACCURACY; ADULT; ARTICLE; BLOOD ANALYSIS; CANNABIS ADDICTION; CANNABIS SMOKING; CAUCASIAN; CONTROLLED STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HISPANIC; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEGRO; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RELIABILITY; SELF REPORT; SMOKING HABIT; URINALYSIS;

AGE FACTORS; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX CHARACTERISTICS;

CANNABIS SATIVA;

EID: 78651469587     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.08.008     Document Type: Article

References (14)

1. Buchan B.J., Dennis M.L., Tims F.M., Diamond G.S. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002, 97(Suppl. 1):98-108.
2. Dennis, M.L., White, M.K., Titus, J.C., Unsicker, J.I., 2006. Global Appraisal of Individual Need (GAIN): administration guide for the GAIN and related measures (version 5). Retrieved 12/31/2009, from http://www.chestnut.org/li/apss/Common/Instruments/gm_5.5.0_gpra_core_review.pdf.
3. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 2000, 68:134-144.
4. Huestis M.A., Cone E.J. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J. Anal. Toxicol. 1998, 22:445-454.
5. Huestis M.A., Cone E.J. Urinary excretion half-life of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans. Ther. Drug Monit. 1998, 20:570-576.
6. Huestis M.A., Gustafson R.A., Moolchan E.T., Barnes A., Bourland J.A., Sweeney S.A., Hayes E.F., Carpenter P.M., Smith M.L. Cannabinoid concentrations in hair from documented cannabis users. Forensic Sci. Int. 2007, 169:129-136.
7. Huestis M.A., Mitchell J.M., Cone E.J. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J. Anal. Toxicol. 1996, 20:441-452.
8. Johnson B.D., Golub A. The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs. Drug Alcohol Depend. 2007, 90(Suppl. 1):S16-S26.
9. Lennox R., Dennis M.L., Ives M., White M.K. The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment. Am. J. Addict. 2006, 15(Suppl. 1):92-101.
10. Lennox R., Dennis M.L., Scott C.K., Funk R. Combining psychometric and biometric measures of substance use. Drug Alcohol Depend. 2006, 83:95-103.
11. Litten R., Allen J. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods 1992, The Humana Press Inc., Totowa, NJ.
12. Preston K.L., Silverman K., Schuster C.R., Cone E.J. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 1997, 92:717-727.
13. Sifaneck S.J., Ream G.L., Johnson B.D., Dunlap E. Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram. Drug Alcohol Depend. 2007, 90(Suppl. 1):S40-51.
14. SPSS for Windows (Version 18.0.0), 2009. SPSS Inc., Chicago.